Saturday, October 31, 2020

Regeneron halts trial of COVID-19 antibody drug in sickest hospitalized patients | TheHill - The Hill

  1. Regeneron halts trial of COVID-19 antibody drug in sickest hospitalized patients | TheHill  The Hill
  2. Trial of Regeneron’s Covid-19 Antibody Drug Is Halted in Sickest Hospital Patients  The Wall Street Journal
  3. 2nd study testing a COVID-19 antibody drug has a setback  Yahoo News
  4. Covid toes could last for 150 days, new research finds  NBC News
  5. Could your smartwatch help detect the next COVID-19 outbreak? San Diego scientists think so  The San Diego Union-Tribune
  6. View Full Coverage on Google News


via Top stories - Google News https://ift.tt/3oGYoMe
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)